Pages that link to "Q57550428"
Jump to navigation
Jump to search
The following pages link to Very High Cytochrome P4501A2 Activity and Nonresponse to Clozapine (Q57550428):
Displaying 13 items.
- What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia (Q28185132) (← links)
- Pharmacokinetics of selective serotonin reuptake inhibitors (Q33837768) (← links)
- Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine (Q33842599) (← links)
- The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis (Q33924143) (← links)
- Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence (Q34156724) (← links)
- Pharmacogenetics of bipolar disorder (Q34577185) (← links)
- Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review (Q35054424) (← links)
- Interactions between the cytochrome P450 system and the second-generation antipsychotics (Q35096587) (← links)
- Pharmacogenomics of psychiatric drug treatment (Q35142052) (← links)
- Identification of a novel splice-site mutation in the CYP1A2 gene (Q35825664) (← links)
- Comment: unanticipated plasma concentrations in two clozapine-treated patients (Q43856297) (← links)
- A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers (Q44292659) (← links)
- Why do schizophrenic patients smoke? (Q45078539) (← links)